Our top pick for
Forte Biosciences Inc is a biotechnology business based in the US. Forte Biosciences shares (FBRX) are listed on the NASDAQ and all prices are listed in US Dollars. Forte Biosciences employs 10 staff and has a market cap (total outstanding shares value) of 0.00.
|Latest market close||$2.70|
|52-week range||$2.64 - $43.57|
|50-day moving average||$6.40|
|200-day moving average||$27.01|
|Wall St. target price||$3.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.61|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-13)||-9.09%|
|1 month (2021-09-20)||-19.64%|
|3 months (2021-07-20)||-91.81%|
|6 months (2021-04-20)||-91.87%|
|1 year (2020-10-20)||-92.23%|
|2 years (2019-10-18)||357.39%|
|3 years (2018-10-19)||11.83|
|5 years (2016-10-16)||N/A|
|Gross profit TTM||$0|
|Return on assets TTM||-30.77%|
|Return on equity TTM||-54.27%|
|Market capitalisation||$39.1 million|
TTM: trailing 12 months
There are currently 1.5 million Forte Biosciences shares held short by investors – that's known as Forte Biosciences's "short interest". This figure is 46.8% down from 2.7 million last month.
There are a few different ways that this level of interest in shorting Forte Biosciences shares can be evaluated.
Forte Biosciences's "short interest ratio" (SIR) is the quantity of Forte Biosciences shares currently shorted divided by the average quantity of Forte Biosciences shares traded daily (recently around 5.4 million). Forte Biosciences's SIR currently stands at 0.27. In other words for every 100,000 Forte Biosciences shares traded daily on the market, roughly 270 shares are currently held short.
However Forte Biosciences's short interest can also be evaluated against the total number of Forte Biosciences shares, or, against the total number of tradable Forte Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Forte Biosciences's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Forte Biosciences shares in existence, roughly 100 shares are currently held short) or 0.1145% of the tradable shares (for every 100,000 tradable Forte Biosciences shares, roughly 115 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Forte Biosciences.
Find out more about how you can short Forte Biosciences stock.
We're not expecting Forte Biosciences to pay a dividend over the next 12 months.
Forte Biosciences's shares were split on a 1:15 basis on 15 June 2020. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Forte Biosciences shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Forte Biosciences shares which in turn could have impacted Forte Biosciences's share price.
Forte Biosciences Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company was incorporated in 2007 and is based in Torrance, California. .
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.